Clinical and immunopathological features of Moyamoya disease

Runhua Lin1, Zeyu Xie, Jianfa Zhang

  • 1Institute of Clinical Pathology & Department of Pathology, Shantou University Medical College, Shantou, Guangdong, People's Republic of China.

Plos One
|May 5, 2012
PubMed
Abstract

Insights

Moyamoya disease involves abnormal IgG and S100A4 protein expression in brain vessels, suggesting immune factors contribute to smooth muscle cell changes and artery narrowing. This may explain the disease

Area of Science:

  • Cerebrovascular disease research
  • Immunopathology of vascular disorders
  • Smooth muscle cell biology

Background:

  • Moyamoya disease (MMD) is a progressive cerebrovascular condition.
  • Characterized by internal carotid artery stenosis and basal brain collateral vessels.
  • Its underlying pathogenesis remains largely unknown.

Purpose of the Study:

  • To investigate the histopathological and immunohistochemical features of intracranial vessels in MMD patients.
  • To explore potential molecular mechanisms contributing to MMD development.

Main Methods:

  • Retrospective analysis of clinical data from 65 MMD patients.
  • Histopathological and immunohistochemical examination of intracranial vessels from 3 autopsy cases.
  • Evaluation of smooth muscle cell changes, IgG, S100A4, and Complement C3 expression.

Main Results:

  • MMD onset peaks between 40-49 years; female-to-male ratio is 1.2.
  • Intracranial hemorrhage is the primary presentation (75%).
  • Histopathology shows intimal thickening, tortuous internal elastic lamina, and vacuolar degeneration; IgG and S100A4 protein are aberrantly expressed in vascular smooth muscle cells.

Conclusions:

  • Aberrant IgG and S100A4 protein expression in MMD intracranial vessels suggests immune involvement.
  • A proposed mechanism involves IgG deposits disrupting the internal elastic lamina, promoting S100A4-positive smooth muscle cell migration and intimal thickening.
  • This process may lead to lumen stenosis, occlusion, and compensatory neovascularization.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...